Politics Rachel Cohrs STAT Plus: House committees strike deal on health transparency, PBM reform package
Pharmalot Ed Silverman STAT Plus: FDA delays enforcement of a pharmaceutical supply chain law to stop counterfeit drugs
Pharmalot Allison DeAngelis STAT Plus: Pharmalittle: This fall’s COVID booster rollout; approval for Pfizer’s RSV vaccine
D.C. Diagnosis Rachel Cohrs STAT Plus: Abortion policy in the spotlight, DeSantis’ importation showdown, and new price hike analysis
Health Tech Lizzy Lawrence STAT Plus: FDA panel votes against high blood pressure device from Medtronic, but lends support to ReCor Medical’s
Health Tech Lizzy Lawrence STAT Plus: FDA advisory panel to debate contentious data on Medtronic’s high blood pressure device
Health Helen Branswell FDA approves Pfizer’s RSV vaccine designed to protect newborns by immunizing parent
Health Nicholas Florko Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.
Biotech Andrew Joseph and Damian Garde STAT Plus: FDA approves first treatment for ultra-rare bone disease
Health Tech Lizzy Lawrence STAT Plus: The latest recall of Philips ventilators reveals one death, two injuries
Pharmalot Ed Silverman STAT Plus: In a rare move, FDA threatens to fine a company for failing to report clinical trial results
Pharmalot Ed Silverman STAT Plus: FDA warns AstraZeneca over misleading promotional materials for a COPD drug
Health Nicholas Florko Patient advocates warn FDA proposal on salt intake could do fatal harm to people with kidney disease
First Opinion Devabhaktuni Srikrishna Home blood pressure machines are often wrong. The FDA must speak up
Biotech Andrew Joseph and Damian Garde STAT Plus: In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need
Health Lizzy Lawrence STAT Plus: Tuberculosis outbreak tied to bone grafts underscores shortcomings of testing
Biotech Erica Goode STAT Plus: Failed clinical trials don’t always spell doom for a new drug. Here’s why
Biotech Brittany Trang STAT Plus: FDA approves Sage Therapeutics’ rapid-acting medication for postpartum depression but not major depression
Pharmalot Ed Silverman STAT Plus: Intas Pharma employee used acid to destroy manufacturing records at troubled plant
Politics Adam Feuerstein and Matthew Herper Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’t hold up to scrutiny
Biotech Jason Mast STAT Plus: Gene therapy is in crisis. For nine hours, the field’s leading minds looked for a solution
Pharmalot Ed Silverman STAT Plus: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls
Pharmalot Ed Silverman STAT Plus: Pfizer says most tornado damage at key plant hit warehouse, but finished drugs also impacted